Veerhealth Care Limited (BSE: 511523)
Health Care · Pharmaceuticals · IN
Rs49.00
+4.95% today · +125.9% 1Y
Veerhealth Care Limited (BSE: 511523) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.24M.
Over the last twelve months the share price has gained 125.9%, trading between 16.70 and 49.95.
Tweenvest scores Veerhealth Care Limited across four factors: quality 65/100, value 58/100, growth 96/100. Its strongest factor is growth.
511523 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.24M
- Revenue (TTM)
- $5.63M
- P/E
- 65.70
- EPS
- 0.75
- Dividend yield
- —
- Beta (5Y)
- 0.13
- 52-week high
- Rs49.95
- 52-week low
- Rs16.70
- Avg volume (3M)
- —
- Shares outstanding
- 20.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.81 | -0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.